LB-1Treatment with Oral ALS-008176, a Nucleoside Analog, Rapidly Reduces RSV Viral Load and Clinical Disease Severity in a Healthy Volunteer Challenge Study. (December 2014) - Devincenzo, John; Fathi, Hosnieh; Mcclure, Matthew; Westland, Christopher; Chanda, Sushmita; Lambkin-Williams, Rob; Smith, Patrick; Harrison, Lisa; Symons, Julian; Scaglioni-Weinlich, Cecilia; Zhang, Qingling; Nieforth, Keith; et al.